Structure

Physi-Chem Properties

Molecular Weight:  482.17
Volume:  503.121
LogP:  5.915
LogD:  3.688
LogS:  -4.002
# Rotatable Bonds:  6
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.326
Synthetic Accessibility Score:  3.234
Fsp3:  0.167
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.123
MDCK Permeability:  2.929638503701426e-05
Pgp-inhibitor:  0.121
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.116
30% Bioavailability (F30%):  0.869

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.032
Plasma Protein Binding (PPB):  100.40428161621094%
Volume Distribution (VD):  0.41
Pgp-substrate:  0.9634755849838257%

ADMET: Metabolism

CYP1A2-inhibitor:  0.181
CYP1A2-substrate:  0.614
CYP2C19-inhibitor:  0.961
CYP2C19-substrate:  0.09
CYP2C9-inhibitor:  0.887
CYP2C9-substrate:  0.975
CYP2D6-inhibitor:  0.186
CYP2D6-substrate:  0.687
CYP3A4-inhibitor:  0.457
CYP3A4-substrate:  0.6

ADMET: Excretion

Clearance (CL):  10.768
Half-life (T1/2):  0.339

ADMET: Toxicity

hERG Blockers:  0.033
Human Hepatotoxicity (H-HT):  0.128
Drug-inuced Liver Injury (DILI):  0.966
AMES Toxicity:  0.052
Rat Oral Acute Toxicity:  0.88
Maximum Recommended Daily Dose:  0.05
Skin Sensitization:  0.936
Carcinogencity:  0.181
Eye Corrosion:  0.003
Eye Irritation:  0.9
Respiratory Toxicity:  0.311

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC3642

Natural Product ID:  NPC3642
Common Name*:   7-Methoxydichamanetin
IUPAC Name:   (2S)-5-hydroxy-6,8-bis[(2-hydroxyphenyl)methyl]-7-methoxy-2-phenyl-2,3-dihydrochromen-4-one
Synonyms:   7-Methoxydichamanetin
Standard InCHIKey:  HUNWUDHAPSHKOD-SANMLTNESA-N
Standard InCHI:  InChI=1S/C30H26O6/c1-35-29-21(15-19-11-5-7-13-23(19)31)28(34)27-25(33)17-26(18-9-3-2-4-10-18)36-30(27)22(29)16-20-12-6-8-14-24(20)32/h2-14,26,31-32,34H,15-17H2,1H3/t26-/m0/s1
SMILES:  COc1c(Cc2ccccc2O)c2O[C@@H](CC(=O)c2c(c1Cc1ccccc1O)O)c1ccccc1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1835969
PubChem CID:   56656188
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3803 Ardisia japonica Species Primulaceae Eukaryota whole plants Sendai, Miyagi Prefecture, Japan 2000-Sep PMID[17243725]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. whole plant n.a. PMID[17243725]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. whole plant n.a. PMID[17397219]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. leaf n.a. PMID[21973101]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. inflorescence n.a. PMID[21973101]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. Kego Nature Reserve, Hatinh Province, Vietnam 2008-DEC PMID[21973101]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. twig n.a. PMID[21973101]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota aerial parts Kego Nature Reserve, Hatinh Province, Vietnam 2008-DEC PMID[21973101]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. stem n.a. PMID[21973101]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. PMID[22940450]
NPO4720 Aglaia perviridis Species Meliaceae Eukaryota leaves, twigs, and fruits Nui Chua National Park (11 43' N; 109 08' E; 730 m alt.), Ninh Thuan Province, Vietnam 2010-Jan PMID[23301897]
NPO4720 Aglaia perviridis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[31621322]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO5657 Oocystis polymorpha Species Oocystaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO4720 Aglaia perviridis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO3803 Ardisia japonica Species Primulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO6614 Rubus pileatus Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO1912 Acanthosyris paulo-alvinii Species Cervantesiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO61 Phoebe grandis Species Lauraceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO992 Betula alnoides Species Betulaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO2846 Piper sarmentosum Species Piperaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens ED50 > 20.0 uM PMID[490786]
NPT139 Cell Line HT-29 Homo sapiens ED50 = 1.6 uM PMID[490786]
NPT2 Others Unspecified ED50 = 3.45 uM PMID[490786]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC3642 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.993 High Similarity NPC122894
0.9789 High Similarity NPC109183
0.9789 High Similarity NPC473078
0.9789 High Similarity NPC470133
0.9789 High Similarity NPC470132
0.9789 High Similarity NPC470131
0.9789 High Similarity NPC470134
0.9718 High Similarity NPC470135
0.9718 High Similarity NPC470136
0.9718 High Similarity NPC39045
0.9658 High Similarity NPC115601
0.9658 High Similarity NPC39154
0.9658 High Similarity NPC208011
0.9658 High Similarity NPC174086
0.9658 High Similarity NPC78324
0.965 High Similarity NPC228779
0.9592 High Similarity NPC121568
0.9586 High Similarity NPC132345
0.9577 High Similarity NPC177354
0.9577 High Similarity NPC64915
0.9577 High Similarity NPC76338
0.9577 High Similarity NPC167624
0.9577 High Similarity NPC324436
0.9577 High Similarity NPC220998
0.9577 High Similarity NPC66515
0.9577 High Similarity NPC37496
0.9577 High Similarity NPC10937
0.9577 High Similarity NPC194432
0.9577 High Similarity NPC40833
0.9577 High Similarity NPC328164
0.9577 High Similarity NPC148757
0.9577 High Similarity NPC125855
0.9577 High Similarity NPC324134
0.9577 High Similarity NPC296917
0.9577 High Similarity NPC1089
0.9577 High Similarity NPC161506
0.9577 High Similarity NPC306829
0.9577 High Similarity NPC182852
0.9577 High Similarity NPC166934
0.9577 High Similarity NPC76372
0.9577 High Similarity NPC228504
0.9577 High Similarity NPC32739
0.9577 High Similarity NPC265040
0.9577 High Similarity NPC107572
0.9577 High Similarity NPC227579
0.9577 High Similarity NPC78
0.9577 High Similarity NPC166482
0.9577 High Similarity NPC223500
0.953 High Similarity NPC1796
0.953 High Similarity NPC475184
0.953 High Similarity NPC257166
0.9527 High Similarity NPC66441
0.9527 High Similarity NPC182555
0.9527 High Similarity NPC134171
0.9527 High Similarity NPC300668
0.9517 High Similarity NPC161191
0.9514 High Similarity NPC267375
0.9514 High Similarity NPC88964
0.9514 High Similarity NPC312973
0.9514 High Similarity NPC20488
0.9514 High Similarity NPC67805
0.9514 High Similarity NPC111786
0.9514 High Similarity NPC470647
0.9514 High Similarity NPC54577
0.9514 High Similarity NPC83357
0.9514 High Similarity NPC301276
0.9514 High Similarity NPC475052
0.9514 High Similarity NPC176229
0.9514 High Similarity NPC142405
0.9514 High Similarity NPC214774
0.9514 High Similarity NPC246948
0.9514 High Similarity NPC195621
0.951 High Similarity NPC257097
0.951 High Similarity NPC278249
0.951 High Similarity NPC125894
0.951 High Similarity NPC214166
0.951 High Similarity NPC164980
0.951 High Similarity NPC185276
0.951 High Similarity NPC81697
0.951 High Similarity NPC77794
0.951 High Similarity NPC478086
0.951 High Similarity NPC143896
0.951 High Similarity NPC150408
0.951 High Similarity NPC68104
0.951 High Similarity NPC85162
0.951 High Similarity NPC39329
0.951 High Similarity NPC169591
0.951 High Similarity NPC149026
0.951 High Similarity NPC221432
0.951 High Similarity NPC175504
0.951 High Similarity NPC91560
0.951 High Similarity NPC310130
0.951 High Similarity NPC75049
0.951 High Similarity NPC223812
0.951 High Similarity NPC316816
0.951 High Similarity NPC107177
0.9507 High Similarity NPC166689
0.9507 High Similarity NPC110038
0.9507 High Similarity NPC17170
0.9507 High Similarity NPC258630
0.9507 High Similarity NPC96408
0.9507 High Similarity NPC26238
0.9507 High Similarity NPC324386
0.9507 High Similarity NPC156190
0.9507 High Similarity NPC4743
0.9507 High Similarity NPC312391
0.9507 High Similarity NPC213322
0.9507 High Similarity NPC248372
0.9507 High Similarity NPC279650
0.9467 High Similarity NPC15815
0.9467 High Similarity NPC51247
0.9467 High Similarity NPC51760
0.9467 High Similarity NPC105584
0.9463 High Similarity NPC69531
0.9463 High Similarity NPC32867
0.9456 High Similarity NPC178484
0.9448 High Similarity NPC23728
0.9448 High Similarity NPC283234
0.9448 High Similarity NPC110303
0.9448 High Similarity NPC296998
0.9448 High Similarity NPC473077
0.9444 High Similarity NPC131568
0.9444 High Similarity NPC131579
0.9444 High Similarity NPC473014
0.9444 High Similarity NPC319752
0.9444 High Similarity NPC236766
0.9444 High Similarity NPC235217
0.9444 High Similarity NPC197252
0.9444 High Similarity NPC473013
0.9444 High Similarity NPC209040
0.9444 High Similarity NPC473015
0.9437 High Similarity NPC6407
0.9437 High Similarity NPC110228
0.9437 High Similarity NPC188243
0.9404 High Similarity NPC42965
0.9404 High Similarity NPC98023
0.9404 High Similarity NPC226462
0.9404 High Similarity NPC195136
0.9396 High Similarity NPC79375
0.9396 High Similarity NPC37253
0.9384 High Similarity NPC160821
0.9384 High Similarity NPC321623
0.9384 High Similarity NPC132592
0.9384 High Similarity NPC189087
0.9379 High Similarity NPC127059
0.9379 High Similarity NPC474161
0.9379 High Similarity NPC476088
0.9379 High Similarity NPC472629
0.9379 High Similarity NPC285630
0.9371 High Similarity NPC14871
0.9371 High Similarity NPC3188
0.9366 High Similarity NPC310135
0.9366 High Similarity NPC222342
0.9366 High Similarity NPC150648
0.9366 High Similarity NPC225153
0.9366 High Similarity NPC274784
0.9366 High Similarity NPC329203
0.9366 High Similarity NPC20709
0.9366 High Similarity NPC265871
0.9366 High Similarity NPC140890
0.9342 High Similarity NPC312273
0.9342 High Similarity NPC301256
0.9338 High Similarity NPC295090
0.9338 High Similarity NPC123544
0.9333 High Similarity NPC198489
0.9333 High Similarity NPC61112
0.9329 High Similarity NPC303485
0.9329 High Similarity NPC290830
0.9329 High Similarity NPC71061
0.9329 High Similarity NPC194593
0.9329 High Similarity NPC72425
0.9324 High Similarity NPC78835
0.9324 High Similarity NPC204561
0.9324 High Similarity NPC317715
0.9324 High Similarity NPC316960
0.9324 High Similarity NPC309512
0.9324 High Similarity NPC148945
0.9324 High Similarity NPC325429
0.932 High Similarity NPC291746
0.932 High Similarity NPC288840
0.932 High Similarity NPC473016
0.9315 High Similarity NPC10990
0.9315 High Similarity NPC300988
0.9315 High Similarity NPC472627
0.931 High Similarity NPC87486
0.931 High Similarity NPC470890
0.931 High Similarity NPC124780
0.931 High Similarity NPC194949
0.931 High Similarity NPC271288
0.931 High Similarity NPC282957
0.9306 High Similarity NPC147145
0.9301 High Similarity NPC159275
0.9301 High Similarity NPC69769
0.9301 High Similarity NPC241100
0.9301 High Similarity NPC76445
0.9301 High Similarity NPC284550
0.9301 High Similarity NPC129853
0.9296 High Similarity NPC243528
0.9296 High Similarity NPC251681
0.9281 High Similarity NPC473012

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC3642 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9267 High Similarity NPD8443 Clinical (unspecified phase)
0.9225 High Similarity NPD1550 Clinical (unspecified phase)
0.9225 High Similarity NPD1552 Clinical (unspecified phase)
0.9195 High Similarity NPD7411 Suspended
0.9178 High Similarity NPD7410 Clinical (unspecified phase)
0.9161 High Similarity NPD1549 Phase 2
0.9091 High Similarity NPD6959 Discontinued
0.9048 High Similarity NPD4378 Clinical (unspecified phase)
0.9038 High Similarity NPD7852 Clinical (unspecified phase)
0.8947 High Similarity NPD2393 Clinical (unspecified phase)
0.8874 High Similarity NPD4380 Phase 2
0.8831 High Similarity NPD7768 Phase 2
0.8774 High Similarity NPD7075 Discontinued
0.8759 High Similarity NPD2796 Approved
0.8701 High Similarity NPD7096 Clinical (unspecified phase)
0.869 High Similarity NPD1510 Phase 2
0.8679 High Similarity NPD6167 Clinical (unspecified phase)
0.8679 High Similarity NPD6168 Clinical (unspecified phase)
0.8679 High Similarity NPD6166 Phase 2
0.8671 High Similarity NPD1240 Approved
0.8636 High Similarity NPD1934 Approved
0.8581 High Similarity NPD7819 Suspended
0.8581 High Similarity NPD7421 Clinical (unspecified phase)
0.8552 High Similarity NPD1607 Approved
0.8535 High Similarity NPD4381 Clinical (unspecified phase)
0.8519 High Similarity NPD7804 Clinical (unspecified phase)
0.8516 High Similarity NPD6801 Discontinued
0.8418 Intermediate Similarity NPD3749 Approved
0.8355 Intermediate Similarity NPD6799 Approved
0.8276 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD7074 Phase 3
0.8239 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8235 Intermediate Similarity NPD1511 Approved
0.8228 Intermediate Similarity NPD2801 Approved
0.8199 Intermediate Similarity NPD5494 Approved
0.8182 Intermediate Similarity NPD7054 Approved
0.8158 Intermediate Similarity NPD3750 Approved
0.8153 Intermediate Similarity NPD6599 Discontinued
0.8151 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8138 Intermediate Similarity NPD4908 Phase 1
0.8133 Intermediate Similarity NPD7472 Approved
0.8129 Intermediate Similarity NPD1512 Approved
0.8125 Intermediate Similarity NPD3882 Suspended
0.8117 Intermediate Similarity NPD7390 Discontinued
0.8092 Intermediate Similarity NPD2800 Approved
0.8084 Intermediate Similarity NPD6797 Phase 2
0.8084 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8077 Intermediate Similarity NPD5403 Approved
0.8072 Intermediate Similarity NPD5844 Phase 1
0.8054 Intermediate Similarity NPD6651 Approved
0.8036 Intermediate Similarity NPD7251 Discontinued
0.8036 Intermediate Similarity NPD6559 Discontinued
0.8013 Intermediate Similarity NPD1551 Phase 2
0.7988 Intermediate Similarity NPD6232 Discontinued
0.7988 Intermediate Similarity NPD7808 Phase 3
0.7952 Intermediate Similarity NPD7473 Discontinued
0.795 Intermediate Similarity NPD3817 Phase 2
0.7949 Intermediate Similarity NPD5401 Approved
0.7908 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7904 Intermediate Similarity NPD3818 Discontinued
0.7902 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD2935 Discontinued
0.7882 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.787 Intermediate Similarity NPD5953 Discontinued
0.7857 Intermediate Similarity NPD7286 Phase 2
0.7857 Intermediate Similarity NPD1243 Approved
0.7848 Intermediate Similarity NPD920 Approved
0.7843 Intermediate Similarity NPD2344 Approved
0.7834 Intermediate Similarity NPD2532 Approved
0.7834 Intermediate Similarity NPD2534 Approved
0.7834 Intermediate Similarity NPD2533 Approved
0.7829 Intermediate Similarity NPD2799 Discontinued
0.7829 Intermediate Similarity NPD3748 Approved
0.7821 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7753 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD5124 Phase 1
0.7748 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD4363 Phase 3
0.774 Intermediate Similarity NPD4360 Phase 2
0.7733 Intermediate Similarity NPD8312 Approved
0.7733 Intermediate Similarity NPD8313 Approved
0.773 Intermediate Similarity NPD5402 Approved
0.7722 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD7033 Discontinued
0.7692 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4628 Phase 3
0.7687 Intermediate Similarity NPD1203 Approved
0.7669 Intermediate Similarity NPD8455 Phase 2
0.7667 Intermediate Similarity NPD2313 Discontinued
0.7662 Intermediate Similarity NPD6100 Approved
0.7662 Intermediate Similarity NPD6099 Approved
0.7655 Intermediate Similarity NPD1610 Phase 2
0.7654 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD6832 Phase 2
0.7643 Intermediate Similarity NPD2309 Approved
0.764 Intermediate Similarity NPD7458 Discontinued
0.764 Intermediate Similarity NPD3226 Approved
0.764 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD1548 Phase 1
0.758 Intermediate Similarity NPD7003 Approved
0.755 Intermediate Similarity NPD3268 Approved
0.755 Intermediate Similarity NPD6798 Discontinued
0.7548 Intermediate Similarity NPD5406 Approved
0.7548 Intermediate Similarity NPD5405 Approved
0.7548 Intermediate Similarity NPD5408 Approved
0.7548 Intermediate Similarity NPD5404 Approved
0.7547 Intermediate Similarity NPD7213 Phase 3
0.7547 Intermediate Similarity NPD7212 Phase 2
0.7514 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2346 Discontinued
0.7485 Intermediate Similarity NPD919 Approved
0.7483 Intermediate Similarity NPD9717 Approved
0.7468 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD3787 Discontinued
0.7451 Intermediate Similarity NPD943 Approved
0.745 Intermediate Similarity NPD2797 Approved
0.7416 Intermediate Similarity NPD4287 Approved
0.7415 Intermediate Similarity NPD422 Phase 1
0.7412 Intermediate Similarity NPD3926 Phase 2
0.7407 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD2654 Approved
0.7403 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD4361 Phase 2
0.74 Intermediate Similarity NPD2798 Approved
0.7399 Intermediate Similarity NPD1729 Discontinued
0.7396 Intermediate Similarity NPD1247 Approved
0.7391 Intermediate Similarity NPD7447 Phase 1
0.7384 Intermediate Similarity NPD3751 Discontinued
0.7384 Intermediate Similarity NPD7177 Discontinued
0.7383 Intermediate Similarity NPD3225 Approved
0.7368 Intermediate Similarity NPD4625 Phase 3
0.7353 Intermediate Similarity NPD5711 Approved
0.7353 Intermediate Similarity NPD7229 Phase 3
0.7353 Intermediate Similarity NPD5710 Approved
0.7349 Intermediate Similarity NPD1465 Phase 2
0.7338 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD1613 Approved
0.7337 Intermediate Similarity NPD6777 Approved
0.7337 Intermediate Similarity NPD6782 Approved
0.7337 Intermediate Similarity NPD6781 Approved
0.7337 Intermediate Similarity NPD6778 Approved
0.7337 Intermediate Similarity NPD6780 Approved
0.7337 Intermediate Similarity NPD6776 Approved
0.7337 Intermediate Similarity NPD6779 Approved
0.7333 Intermediate Similarity NPD5889 Approved
0.7333 Intermediate Similarity NPD5890 Approved
0.7302 Intermediate Similarity NPD8151 Discontinued
0.729 Intermediate Similarity NPD1933 Approved
0.7289 Intermediate Similarity NPD7577 Discontinued
0.7287 Intermediate Similarity NPD7584 Approved
0.7273 Intermediate Similarity NPD7871 Phase 2
0.7273 Intermediate Similarity NPD6233 Phase 2
0.7273 Intermediate Similarity NPD7870 Phase 2
0.7261 Intermediate Similarity NPD4308 Phase 3
0.726 Intermediate Similarity NPD9545 Approved
0.7248 Intermediate Similarity NPD3972 Approved
0.7243 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6273 Approved
0.7222 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD3266 Approved
0.7219 Intermediate Similarity NPD7696 Phase 3
0.7219 Intermediate Similarity NPD7435 Discontinued
0.7219 Intermediate Similarity NPD3267 Approved
0.7219 Intermediate Similarity NPD7697 Approved
0.7219 Intermediate Similarity NPD7698 Approved
0.7216 Intermediate Similarity NPD6104 Discontinued
0.7208 Intermediate Similarity NPD3764 Approved
0.7202 Intermediate Similarity NPD4288 Approved
0.7197 Intermediate Similarity NPD7097 Phase 1
0.7193 Intermediate Similarity NPD7199 Phase 2
0.719 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6844 Discontinued
0.7184 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD1201 Approved
0.7179 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6585 Discontinued
0.7168 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD1241 Discontinued
0.7135 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7783 Phase 2
0.7133 Intermediate Similarity NPD1608 Approved
0.7125 Intermediate Similarity NPD2424 Discontinued
0.7124 Intermediate Similarity NPD2861 Phase 2
0.7124 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD9493 Approved
0.7111 Intermediate Similarity NPD8150 Discontinued
0.711 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD1470 Approved
0.7101 Intermediate Similarity NPD2296 Approved
0.7097 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD1296 Phase 2
0.7086 Intermediate Similarity NPD4749 Approved
0.7081 Intermediate Similarity NPD1652 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data